Podcasts about pharmaceuticals

Jenny Opalinski has spent more than a decade inside hospitals where people lose the ability to speak, breathe, swallow, and sometimes survive. A medical speech language pathologist by training, she worked in ICU, neuro rehab, and long term acute care settings, including a Level 1 trauma center, where she watched clinicians absorb 10 to 15 traumatic events in a single shift and then get told to move the crash cart faster next time.That lived reality pushed her to co found The Wellness Shift, an advocacy and education platform focused on healthcare worker burnout, suicide, and assault. In this conversation, Opalinski walks through the moment that changed everything for her: standing in a hospital hallway listening to a family wail after a failed code, followed by a debrief that addressed logistics and ignored grief entirely.She also explains how that work led to Humanity Rx, her podcast about the human cost of medicine, and Dragon's Breath: Calming Tricks for Big Feelings, a children's book that translates evidence based breathing and regulation strategies into language kids can actually use. The episode covers moral injury, time scarcity, false wellness, respiratory muscle training, and why empathy keeps getting treated as an optional expense instead of clinical infrastructure.RELATED LINKSJenny Opalinski on LinkedInHumanity Rx PodcastFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Plastic keeps getting made, it never goes away, and almost none of it gets recycled. Dr. Judith Weis, Professor Emerita at Rutgers University Newark and Andrew's very first guest on this podcast more than 2,000 episodes ago, returns for her fourth appearance to talk about the second edition of her book, Marine Pollution: What Everyone Needs to Know. Judith walks through every major category of marine pollution: nutrients, metals, oil, pesticides, marine debris, pharmaceuticals, ocean acidification, and one category that surprises most people, biological pollution. She explains why microplastics earned a brand new chapter, why they're so hard to study when they're in every lab and every body, and what Canada's legal fight over listing plastic as toxic means for regulation. There's good news too. Judith grew up near a Hudson River full of raw sewage. After the Clean Water Act and new treatment plants, New Yorkers now walk the waterfront, the water is swimmable in dry weather, and humpback whales feed in New York Harbor. Andrew and Judith ask what that comeback can and can't teach us about plastic, and what you can do today. Takeaways: Every major type of marine pollution comes down to three questions: where it comes from, what it does, and what we can do about it. Judith calls plastic the number one villain in marine pollution today because production keeps rising and recycling doesn't work at scale. Microplastics are 5 mm or smaller, mostly invisible, and carry chemicals both inside them and stuck to their surfaces. They're so widespread that researchers struggle to find microplastic-free controls for experiments. Canada listed plastic manufactured items as toxic under CEPA, banned six single-use categories, and saw that listing upheld on appeal. Large tanker spills have become far less common, with double hulls part of the reason. Sewage treatment after the Clean Water Act transformed the Hudson River and New York Harbor, and whales are back. Pharmaceuticals and hormones pass through treatment plants and change fish behavior and biology. Invasive species count as biological pollution, and unlike chemicals, they reproduce. Beach cleanups, local environmental chapters, and cutting your own plastic use are practical places to start. Buy the book: https://global.oup.com/academic/product/marine-pollution-9780197753811?cc=ca&lang=en& Join the newsletter Need help with your ocean non-profit, company, or project? Get the help you need with Pisces Oceans Inc.: https://www.piscesoceans.ca Connect with Speak Up For Blue Website: https://bit.ly/3fOF3Wf Instagram: https://bit.ly/3rIaJSG TikTok: https://www.tiktok.com/@speakupforblue Twitter: https://bit.ly/3rHZxpc YouTube: www.speakupforblue.com/youtube    

As specialty drugs play an increasingly important role in patient care, 340B hospitals need to be planning for how to obtain these high-cost medications when they come online and how best to support their patients once they start using these treatments. Tina Do is associate director of clinical strategy and business development at Yale New Haven Health. She discusses the ways her health system has achieved success in connecting patients with some of the most complex and costly specialty drugs and what other hospitals can learn from those examples. Why Specialty Drugs Are Key for 340B HospitalsDo says specialty drugs are becoming more important to the 340B world for much the same reason they are becoming more important in the health care system. More than 70% of drugs in development are specialty drugs, including numerous therapies that are considered ultra-specialty drugs. That makes it imperative for 340B hospitals to be considering the projected costs of these drugs and the often-substantial amount of patient support that is necessary for people who need these complex therapies.Hospitals Must Anticipate Upcoming Drug TherapiesDo argues that hospitals need to be monitoring medications coming down the pharmaceutical pipeline because of all the strategic conversations that need to happen within and outside of a pharmacy. Hospitals might need to acquire certain equipment or technology to support these therapies and make plans for the financial impact of new treatments on both the health system and the patients.What Hospitals Need to Figure Out Ahead of TimeBefore new treatments come online, Do says health systems need to ask numerous questions about accessing and administering them. Is a specialty medication going to be a limited distribution drug? Will the medication be part of payer contracts? How many patients and prescribers are affiliated with a particular health service and might be interested in receiving or prescribing the medication? How can the hospital help patients stay on this complex therapy and access financial assistance when necessary? Figuring out the answers to these questions well ahead of time will go a long way in setting up the hospital and its patients for success.

As populations age and health systems face mounting pressures, precision medicine offers a powerful shift from reactive treatment to proactive, personalized prevention. However, key hurdles remain, from breaking down data silos and navigating provincial jurisdictions to maintaining public trust and closing equity gaps across rural and urban communities.

As many of our listeners know from news reports, emergency departments have been under enormous strain in recent years trying to manage overcrowding, the opioid addiction crisis, the consequences of an under-resourced mental health system, and rising rates of violence against staff, among many other challenges. But our guest today guest thinks there's something else that should top that list. "I think hands down the most important issue is the reimbursement model," says Dr. Ryan Stanton, president-elect of the American College of Emergency Physicians. Dr. Stanton's uniquely-informed view is built on his work leading a physician-owned group staffing two Kentucky emergency departments, serving as EMS medical director for Lexington-Fayette County, and overseeing on-track medical response crews for auto racing series such as NASCAR. In this candid conversation with Raise the Line from Elsevier host Lindsey Smith, Dr. Stanton traces how underpayment from insurers is squeezing physicians and warping the incentives of emergency care, and why he believes the profession's ability to advocate collectively, not individually, is what will move the needle. This informative episode also explores: Why he thinks physician autonomy is the antidote to burnout; His approach to communicating medical information as a TV commentator; What it's like providing care at a NASCAR race when the “car is still smoking.” Mentioned in this episode: American College of Emergency Physicians If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Bob Duggan is a billionaire entrepreneur and investor best known for helping transform Pharmacyclics from a struggling biotech company into a cancer-treatment powerhouse that sold for $21 billion.In this episode, Bob shares his journey from a modest childhood and early investing career to building businesses across food, robotics, healthcare, and pharmaceuticals. He opens up about losing his son to glioblastoma, how that experience shaped his commitment to medicine, and the principles behind his approach to risk, leadership, investing, responsibility, and wealth creation.Find Bob Duggan here:Website: https://robertduggan.com/ Genius Inc.: https://www.geniusinc.com/LinkedIn: https://www.linkedin.com/in/robertwduggan Pulse Biosciences: https://www.pulsebiosciences.com/ Summit Therapeutics: https://www.smmttx.com/overview/ Duggan Investments: https://www.dugganinvestmentsresearch.com/Hosted on Ausha. See ausha.co/privacy-policy for more information.

Vanda Pharmaceuticals, Inc. v. FDA

Fitz Koehler is a fitness expert, race announcer, author, and breast cancer survivor whose career spans decades of helping people move, train, and live healthier lives. After earning a master's degree in exercise and sport sciences, she built the Fitzness brand, launched the Morning Mile school fitness program, and became one of the country's most recognizable voices at endurance events before cancer abruptly shifted the conversation. She spent 15 months enduring chemotherapy, surgery, and radiation after discovering breast cancer shortly after receiving a clean mammogram. She kept traveling, announcing races, and working through treatment while watching the body she had spent a lifetime building become weaker by the week. Instead of asking why cancer happened, she focused on the only things she believed remained under her control: movement, nutrition, sleep, and mental health. The conversation explores where personal agency ends and biology takes over. Koehler argues that exercise is not about chasing perfection or preventing every diagnosis. It is about building physical reserve before illness arrives and preserving strength, mobility, and independence during treatment. She rejects wellness snake oil, fad supplements, and miracle cures in favor of practical habits rooted in exercise science and lived experience. The discussion also confronts a harder truth. Koehler did everything “right” and still developed cancer. That tension becomes the center of the episode. Fitness cannot eliminate randomness, but it can influence how people experience treatment, recover from surgery, and reclaim their lives afterward. The conversation moves beyond motivation and into survivorship, exercise oncology, cancer rehabilitation, evidence-based nutrition, and the limits of individual control inside a healthcare system that often tells patients what they should do without showing them how to do it. Along the way, the conversation wanders through kickboxing, Cinnabon, Jean-Claude Van Damme, chocolate-covered Cheetos, Jerry Seinfeld playing during chemotherapy stretches, and why the simplest advice is often the hardest to follow. Beneath the humor sits a larger argument: preparing the body for hardship is not about living forever. It is about living better when life inevitably gets difficult. RELATED LINKSFitz Koehler⁠Fitzness⁠The Morning Mile⁠You. Supercharged!⁠My Noisy Cancer Comeback⁠Your Healthy Cancer Comeback⁠UF Health Cancer Center⁠American College of Sports Medicine Exercise Is Medicine⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

John Maytham speaks to Khadija Jamaloodien about South Africa’s ongoing shortages of essential medicines and efforts to stabilise the country’s medicine supply. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Send us Fan MailWhat if the problem isn't that your immune system can't see the cancer - but that the cancer has effectively reprogrammed the immune cells around it?Faron Pharmaceuticals is pursuing a very different strategy: using an antibody called bexmarilimab to target Clever-1 on macrophages and potentially change an immunosuppressive tumor environment into one that can support an anti-cancer immune response.Today we're going inside that strategy - and asking what the clinical evidence actually tells us so far.Dr. Joab Williamson, Ph.D. is Vice President of Operations at Faron Pharmaceuticals ( https://faron.com/ ), a clinical-stage biopharmaceutical company developing novel immunotherapies designed to address some of the most difficult-to-treat cancers.Dr. Williamson brings a particularly interesting perspective to this discussion. At Faron, he leads clinical operations, clinical supply and clinical science activities, while helping guide programs from development strategy through execution. His background spans clinical development, program management and pharmaceutical operations, and he has also completed a PhD in Health Economics and Pharmacoeconomics focused on how strategic drug-development decisions can affect the value and ultimately the path of a therapeutic program.Faron's lead program is bexmarilimab, an investigational antibody targeting Clever-1, a receptor found on immunosuppressive macrophages. The idea is that by targeting Clever-1, these macrophages can be reprogrammed from a tumor-supporting, immunosuppressive state toward an immune-stimulating state - potentially helping the immune system recognize and attack cancer more effectively.The program is particularly advanced in higher-risk myelodysplastic syndromes, or HR-MDS, and is also being investigated in acute myeloid leukemia and several solid tumors. Recent data from the BEXMAB program have reported durable responses in HR-MDS, while Faron is now moving toward a randomized Phase 2b study and expanding the investigation of bexmarilimab into additional treatment settings.And that brings us to an especially interesting point in the program: the transition from promising clinical science to the much harder question of actually executing the trials that can determine whether that science translates into a meaningful new treatment.#FaronPharmaceuticals #Bexmarilimab #CancerImmunotherapy #Immunotherapy #Leukemia #AML #MDS #MyelodysplasticSyndromes #BloodCancer #Clever1 #Macrophages #TumorMicroenvironment #CancerResearch #ClinicalTrials #Biotechnology #Biotech #DrugDevelopment #PrecisionMedicine #MedicalInnovation #ProgressPotentialAndPossibilitiesSupport the show

Limiting the side effects of cancer treatments has been an animating force in the field of oncology for many years, and there's been progress to report on that front, but what if you could target cancer tumors without using radiation or chemotherapy and instead generate heat from inside the tumor to kill cells? That's the quest of our guest today, Dr. Hadiyah-Nicole Green, whose promising research using lasers and nanoparticles to eliminate tumors received Breakthrough Device Designation from the FDA earlier this year. “The laser beam that we're using is low power like a laser pointer, and without activation by the laser, the nanoparticles are harmless. Both are targeted just at the site of the tumor so because we don't use systemic delivery, we avoid all of the systemic side effects,” she explains.Dr. Green is also the founder and president of the Ora Lee Smith Cancer Research Foundation, named for an aunt who raised her and who died of cancer without pursuing curative treatment because of her fear of the side effects. Shortly after, her aunt's husband also died of cancer, opting for treatments that took a heavy toll on his body. “At 22 years old, I saw the horrors of cancer and the horrors of cancer treatment and just felt in my heart that there has to be something better than this,” she tells host Michael Carrese.On this fascinating episode of Raise the Line from Elsevier, we'll explore the science behind Dr. Green's approach, the challenges of raising the millions of dollars needed for human clinical trials, and rethinking the current funding landscape for cancer treatments.Mentioned in this episode:Ora Lee Smith Cancer Research Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this special Sickle Cell Warrior Takeover of Cheat Codes, Kyle Smith and Shamonica Wiggins-Mayes sit down with Brian Goff, CEO of Agios Pharmaceuticals, for a candid conversation about the relationship between the sickle cell community and the biopharma industry. They discuss what meaningful partnership looks like, why trust must be earned over time, and how listening to people with lived experience can shape research, education, and drug development. Brian also reflects on what he has learned from the sickle cell community, while Kyle and Shamonica share what they want industry leaders to better understand about the realities of living with sickle cell disease.   SHOW DESCRIPTION Cheat Codes is intended for patients, caregivers, providers, and the greater community of people who are impacted by Sickle Cell Disease.  Each episode, Cheat Codes strives to provide listeners with critical education, the latest scientific updates, and voices from the Sickle Cell community.     Join an inclusive community and build connections with other hemolytic anemia allies by following @AllyVoicesRising on Instagram.   TRANSPARENCY STATEMENT  Cheat Codes: A Sickle Cell Podcast is made possible by Agios Pharmaceuticals Inc. Visit Agios.com to learn more. The following Agios-supported programs are intended for informational and educational purposes only and are not intended as medical advice. Please speak with your healthcare professional before making any treatment decisions. Hosts Drs. Ahmar Zaidi and Mike Callaghan are Agios employees. Guests have been compensated for their time.  

The popular belief that pharmacy technicians are solely focused on dispensing drugs is a common misconception, especially when these techs are working for 340B hospitals. We speak about the increasingly important role pharmacy techs are playing in the 340B world with Dartmouth Health Senior 340B Analyst Kayla Ciampi. Getting Into the 340B WorldAfter having limited experiences with 340B earlier in her career, Ciampi said things became “340B on steroids” once she moved to Dartmouth Health. Now much of her day-to-day responsibilities revolve around 340B purchasing and compliance issues, involving significant amount of time working with Excel, third-party administrators, and 340B claims auditing. She said what keeps her coming back are the challenges she tackles and the satisfaction she gets from finding solutions after hours of research.The Changing 340B Roles of Pharmacy TechsCiampi says pharmacy techs are working hard figuring out when to purchase drugs on 340B accounts, ordering for contract pharmacies, and keeping track of increasing drugmakers restrictions. Techs are doing much of the analytical work behind the scenes to make sure 340B claims are eligible, making them a key part of the compliance infrastructure at hospitals.Advice for Other TechsAs the 340B world picks up speed, Ciampi said being a pharmacy tech in that field can feel like being on a fast-moving freight train and trying to see what's happening outside. Because of how rapidly that landscape is changing, she says attention to detail, a willingness to adapt, and a desire to learn are the keys to 340B success for techs.Resources340B Health Urges CMS To Abandon Proposed Medicare Cuts to 340B Hospitals

"It's really hard to justify a test that has any complications if there isn't any reasonable expectation of benefit," says Dr. Rita Redberg, who has spent her career trying to help fellow clinicians consider the actual value of routine screenings and diagnostic testing in asymptomatic patients. Dr. Redberg -- a cardiologist and professor of medicine at the University of California, San Francisco for more than three decades -- is one of the leading voices advocating for a “high-value care” approach, an uphill fight in a healthcare system that tends to reward action over restraint. Her highest profile effort was launching the instructive “Less is More” series in JAMA Internal Medicine when she served as its editor-in-chief for 14 years. On a related track, her research on the assessment of the safety and effectiveness of medical technology, specifically high-risk cardiovascular devices, has yielded a troubling picture. "We found only 1% of devices enter the market through the FDA's most rigorous approval process. The high-quality evidence to support benefit for these devices that I had assumed was present, wasn't actually there.” Join Raise the Line host Lindsey Smith for an eye-opening exploration of what Dr. Redberg considers to be the overlooked risks and false reassurance of common tests and procedures, and her efforts to put the “do no harm” principle of medicine at the forefront of everyday practice.Mentioned in this episode:UCSF School of MedicineJAMA Internal Medicine's Less is More Series If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

On this episode of Vitality Radio, Jared kicks off a 4 part series challenging the way we think about symptoms. Are fever, inflammation, and pain problems to eliminate, or intelligent responses designed to protect and repair the body? Jared explores why the body creates these signals, what they may be trying to accomplish, and what can happen when we automatically suppress them. He examines fever and immune response, inflammation and tissue repair, pain as protective communication, and the widespread use of acetaminophen, NSAIDs, and opioids. You'll also hear the troubling history of Vioxx and OxyContin and why understanding the cause behind a symptom matters. This episode offers a different framework - listen to what your body is telling you before simply trying to silence the signal. Additional Information:***Watch for all 4 parts of this series on Symptoms!Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.This podcast is produced by DrTalks.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drtalks.com/podcast-service/

September has been a rough month already for Novo Nordisk, which canned two more late-stage trials of its embattled IL-6 inhibitor, and Novartis, which took Phase 3 hits in both cardiovascular and muscular dystrophy indications; Ultragenyx's big bet in Angelman syndrome failed to yield benefit in Phase 3 but Ionis' Pharmaceuticals nabbed the first targeted approval for Alexander disease; and on the business side, biopharma investment is back in a big way. 

Plus: Amgen has its worst day in more than two decades. And quantum-computing companies rally after U.S. government picks up minority stakes. Imani Moise hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

LEARN about Sean's coaching here - seanmccormick.com Get stocked up on Natural Stacks products here and watch for Stacks Day! - https://www.naturalstacks.com/OPP15 Check out Peluva - Five-Toed Barefoot Shoes HERE Use code "OPTIMAL" for a discount!   Overview   Sean McCormick and Roy Krebs from Natural Stacks discuss the evolution of brain health and nootropics, focusing on the development of Natural Stacks and the importance of quality in supplements. They explore personal experiences with nootropics, the benefits of perizanthine, and the impact of GLP-1 medications on dopamine levels and personality. The discussion also delves into the role of neurotransmitters in shaping personality and practical applications for improving brain health. In this conversation, Sean McCormick and Roy delve into the intricacies of brain health, focusing on the importance of understanding neurotransmitters and the impact of diet and lifestyle on mental well-being. They discuss the role of nootropics, the dangers of psych medications, and the potential of natural alternatives. The conversation also touches on the future of health supplements, the influence of AI in drug development, and the significance of personal introspection in achieving mental clarity and health.TakeawaysRoy founded Natural Stacks to address his own brain health issues. The nootropic industry has evolved significantly over the years. Personal experimentation with supplements can lead to better brain function. Perizanthine offers a clean energy boost without the side effects of caffeine. Quality control in supplement manufacturing is crucial for consumer safety. GLP-1 medications can dampen dopamine receptors, affecting personality. Understanding neurotransmitters can help individuals optimize their mental health. The Braverman assessment is a valuable tool for understanding neurotransmitter dominance. There is a historical connection between personality theories and neurotransmitter levels. Natural Stacks focuses on transparency and quality in their products. Experiment with nootropics to find what works for you. Understanding neurotransmitters is key to mental health. Dopamine is crucial for motivation and drive. Acetylcholine affects memory and cognitive clarity. Serotonin influences mood and stress management. GABA is important for anxiety and calmness. Diet plays a significant role in neurotransmitter balance. There are many alternatives to pharmaceuticals for mental health. The future of health supplements is promising with AI advancements. Introspection is essential for personal growth and understanding.titlesUnlocking Brain Health: The Power of Nootropics Neurotransmitters: The Key to Mental Well-Being Beyond Psych Meds: Exploring Natural Alternatives Diet and Mental Health: A Critical Connection The Future of Supplements: AI and Personalized Health Motivation and Growth: Finding Your Path Introspection: The First Step to Self-Understanding   Chapters   00:00 Introduction to Brain Health and Nootropics   02:50 The Evolution of Natural Stacks and Nootropic Industry   06:07 Personal Experiences with Nootropics   09:06 Understanding Perizanthine and Its Benefits   12:02 Quality Control in Supplement Manufacturing   14:45 The Impact of GLP-1s on Dopamine and Personality   21:44 Neurotransmitters and Their Role in Personality   30:06 Practical Applications of Neurotransmitter Knowledge   36:22 Nootropics and Personal Experimentation   37:25 Understanding Neurotransmitters   40:33 The Role of Neurotransmitters in Mental Health   43:53 The Impact of Psych Meds on Mental Health   46:37 Exploring Alternatives to Pharmaceuticals   49:07 Diet and Its Influence on Mental Health   51:29 The Future of Supplements and Pharmaceuticals   56:36 The Intersection of AI and Health   62:15 Motivation and Personal Growth   71:27 Introspection and Self-Understanding              

Jeremy Heffner, MD, FACS is a board-certified trauma surgeon, former Chair of Surgery at Lima Memorial Health System, and cofounder of Surgery Unified, one of the largest physician-led communities in surgery. His perspective carries weight because he has spent decades inside operating rooms, hospital leadership, physician culture, and the growing collision between medicine and corporate healthcare. He grew up in a blue-collar Ohio family of firefighters, railroad workers, police officers, and tradespeople. Medicine represented something rare: a career that combined service, stability, and purpose. He pursued engineering, earned his medical degree, completed trauma surgery fellowship training at the University of Michigan, and entered a profession that taught physicians to sacrifice themselves for patients.Then the rules changed.This conversation traces the gap between the medicine physicians were trained to practice and the healthcare industry that emerged around them. Administrative burden expanded. Insurance companies gained influence over treatment decisions. Prior authorization became routine. Hospital systems consolidated. Physicians retained responsibility for outcomes while losing authority over the conditions required to achieve them.Heffner describes watching colleagues struggle with burnout, moral injury, PTSD, and growing frustration with a system that increasingly inserts business incentives between clinicians and patients. He explains why younger physicians are entering medicine with a level of visibility that previous generations never had. They see the paperwork, the denials, the loss of autonomy, and the personal cost before they ever finish training.The discussion moves beyond physician dissatisfaction and into the broader consequences for patients. When insurers delay care, hospitals absorb costs, clinicians absorb stress, and patients absorb uncertainty. The financial incentives remain intact while trust erodes across every level of the healthcare system.At its core, this episode examines what happens when a profession built around service finds itself operating inside an industry built around extraction. The result affects physicians, nurses, caregivers, and every patient forced to navigate the consequences.RELATED LINKSJeremy Heffner⁠Surgery Unified⁠SurgeOn⁠University of Michigan Department of Surgery⁠KevinMD⁠Suck It Up Buttercup⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 1971, the National Cancer Act transformed cancer into a national research priority. More than 50 years later, the next frontier is no longer defined solely by scientific discovery, but by how quickly knowledge, lived experience, and patient voices can reshape healthcare itself.The concluding chapter of The Cancer Mavericks: A History of Survivorship explores how the cancer advocacy movement continues to evolve in an era of digital communities, social media, precision medicine, and grassroots activism. Building on the work of pioneers such as Mary Lasker, Rose Kushner, and the generations of survivors who followed, today's advocates are expanding the movement beyond awareness to demand health equity, trusted information, patient-centered research, and meaningful representation in healthcare decision-making.The episode examines how technology has transformed advocacy from local support groups into global communities capable of organizing in real time. Researchers, policymakers, nonprofit leaders, and survivors reflect on the growing influence of digital storytelling, online education, and peer-to-peer networks that connect patients across diagnoses, generations, and geographic boundaries. At the same time, they acknowledge new responsibilities: ensuring accurate medical information, combating misinformation, protecting trust, and keeping patients at the center of innovation.The story also looks ahead to the next generation of advocates. Young leaders are applying lessons learned from decades of cancer activism while drawing inspiration from broader movements for social justice, public health, and community organizing. Their work reflects a simple but enduring truth: meaningful change rarely begins inside institutions. It begins when ordinary people refuse to accept that the system cannot improve.Cancer survivorship has never been a finished story. Every generation inherits the progress achieved by those who came before while confronting challenges uniquely its own. The future of survivorship will be shaped not only by scientific breakthroughs, but by those willing to listen, organize, educate, and ensure that every patient's voice helps define what comes next.RELATED LINKSNational Cancer Institute⁠Cancer Moonshot⁠Centers for Disease Control and Prevention | Division of Cancer Prevention and Control⁠HopeLab⁠Tigerlily Foundation⁠Stupid Cancer⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

For millions of young women and girls, often the first place they turn with questions about their bodies isn't a doctor's office, it's social media which can lead to encountering many misconceptions and outright misinformation. Or, if the right voices show up, it can mean something else entirely. Our guest today, Dr. Charis Chambers, is one of those voices. She's a board-certified OB/GYN with specialty certification in Pediatric & Adolescent Gynecology, and Chief Medical Officer at Clue, a leading period and cycle-tracking app. She's also the founder of The Period Doctor, a platform she launched in 2019 to provide medically accurate reproductive health information and to place more minority physicians in the spaces where patients are already looking for answers. As she tells Raise the Line from Elsevier host Lindsey Smith, Dr. Chambers embraces the role of being a bridge between generations: "I can serve as a medical mediator where I advocate for the child and then educate the parent so that the child's concerns are met." Stay tuned to this important conversation to also learn about: Her new book, The Period and Puberty Parenting Revolution, which tackles many of the same myths she encounters every day in her clinic; Why stubborn myths around periods rarely hold up once you ask where they come from; How she thinks about the responsibility, and limits, of being a trusted medical voice on social media. Mentioned in this episode: Clue The Period Doctor The Period and Puberty Parenting Revolution If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Love the show? Have any thoughts? Click here to let us know!This week, we're heading to the Northeast for some strange and spooky stories from Connecticut! First, Lauren shares an unusual true crime story involving the largest pharmaceutical heist in U.S. history. A multimillion-dollar theft that sounds more like the plot of a Hollywood movie than a real crime. Then, Kenzie takes us out onto the waters of the Long Island Sound to explore the history and paranormal legends surrounding two of Connecticut's haunted lighthouses: Penfield Reef and Sheffield Island. From millions of dollars in stolen drugs to lighthouse keepers who may have never truly left their posts, join us as we explore the criminal and supernatural side of the Constitution State!--Follow us on Social Media and find out how to support A Scary State by clicking on our Link Tree: https://instabio.cc/4050223uxWQAl--Have a scary tale or listener story of your own? Send us an email to ascarystatepodcast@gmail.com! We can't wait to read it!--Thinking of starting a podcast? Thinking about using Buzzsprout for that? Well use our link to let Buzzsprout know we sent you and get a $20 Amazon gift card if you sign up for a paid plan!https://www.buzzsprout.com/?referrer_id=1722892--Works cited!https://docs.google.com/document/d/1VgqLQokaZhiy7s7tspN6_4aueaVSW-TOsuZYM_iPjd4/edit?usp=sharing --Intro and outro music thanks to Kevin MacLeod. You can visit his site here: http://incompetech.com/. Which is where we found our music!

In 1987, Mary P. Lovato, a member of Kewa Pueblo in New Mexico, was diagnosed with acute leukemia. To receive a bone marrow transplant, she had to travel more than 800 miles from home because specialized cancer care was unavailable through the Indian Health Service. When she returned, she discovered another obstacle: many in her community feared cancer so deeply that they avoided speaking about it altogether.This episode examines how cancer survivorship exposed profound inequities in the American healthcare system. Long before health equity became a national priority, advocates from underserved communities were confronting disparities rooted in geography, poverty, racism, language, underfunded healthcare systems, and historical mistrust of medical institutions. Their work demonstrated that scientific advances alone cannot improve survival if patients cannot reach, afford, or trust the care available to them.The story follows pioneers including Mary P. Lovato, who built the first national Native-led cancer support and education program for Indigenous communities, and Maimah Karmo, founder of the Tigerlily Foundation, whose breast cancer diagnosis inspired a movement to improve early detection, clinical trial participation, and representation for Black women. Their advocacy challenged longstanding barriers to culturally competent care while highlighting persistent inequities in access to screening, fertility preservation, navigation, and innovative treatments.The episode also explores why diversity in clinical research matters. For decades, many cancer clinical trials disproportionately enrolled White patients, limiting both access to promising therapies and the scientific understanding of how treatments perform across different populations. Researchers, patient advocates, and community leaders responded by redesigning outreach, improving patient navigation, reducing logistical barriers, and insisting that affected communities help shape the research itself.Cancer survivorship cannot be measured solely by scientific breakthroughs. It also depends on whether every patient has a meaningful opportunity to benefit from them. The pursuit of health equity remains one of the defining challenges and enduring responsibilities of modern oncology.RELATED LINKSNational Cancer Institute | Cancer Health Disparities⁠Indian Health Service⁠Tigerlily Foundation⁠National Cancer Institute | Cancer Clinical Trials⁠American Indian Cancer Foundation⁠Abramson Cancer Center | University of Pennsylvania⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

There are a LOT of assumptions floating around about what it's actually like to work with a naturopath:It's going to cost me a fortuneI'll walk away taking 47 supplementsThey're going to make me overhaul my entire lifeI'll need thousands of dollars worth of functional testingAnd surely naturopaths are anti-pharmaceuticals… right?Well… not quite!In this episode, we're tackling some of the most common fears, objections and misconceptions we hear about naturopathic care — and explaining what good, strategic naturopathy should actually look like.FIND NAT BELOW:Website - https://nataliekdouglas.com/Instagram - https://www.instagram.com/natalie.k.douglasBook a Free Assessment Call - https://NatalieKDouglas.as.me/?appointmentType=50255874EndoNourish - Endometriosis and Adenomyosis Guide - https://nataliekdouglas.com/endonourish-holistic-endometriosis-adenomyoisis-care-guide/SacredSeeds - Preconception Care Guidehttps://nataliekdouglas.com/preconception-care-guide/PCOS Wellness Guidehttps://nataliekdouglas.com/pcos-holistic-guide/Thyroid Rescue - Self guided programhttps://nataliekdouglas.com/thyroid-rescue/Coming Off The Pill/IUD Holistic Guidehttps://nataliekdouglas.com/coming-off-the-pill-mini-course/PMS/PMDD Natural Solutons Masterclass https://nataliekdouglas.com/pms-pmdd-natural-solutions-masterclass/Restore and Nourish Gut Reset - https://nataliekdouglas.com/restore-nourish-gut-reset/Perimenopause Masterclass -https://nataliekdouglas.com/perimenopause-masterclass-holistic-toolkit/Become a one-to-one clienthttps://nataliekdouglas.com/1-1-naturopathic-nutrition-consultations/FIND AMIE BELOW:Book a Free Assessment Call: https://p.bttr.to/3yBdmu3   Book Yourself In: https://l.bttr.to/ZDxWOWebsite - https://whatthenaturopathsaid.com   Instagram - https://www.instagram.com/thatnaturopathJoin the mailing list - https://elysium-clinic-of-natural-medicine.ck.page/69663ce14a  PS: yes we are practitioners, but we're not YOUR practitioners - it should go without saying but our episodes are not medical advice.

A key dimension to navigating 340B involves data, because the way hospitals and their pharmacies crunch numbers can be key to avoiding compliance issues and finding new opportunities to improve savings and patient access to care. Saint Francis Health System's 340B Program Manager Ted Houston tells us how his health system is getting the most value out of all the data.Compliance and Savings OpportunitiesHouston says his health system has put in a lot of work with its enterprise and data analytics team to align what the electronic health record system is exporting to what drug companies are demanding in order to improve compliance. But he said improving reports also led to additional savings for his system, as some claims were miscategorized within third-party administrator systems. Data Consolidation, Better WorkflowsHouston said health systems can improve their data monitoring by reducing individual data sources — for example, by using a standardized data extract from a third-party administrator and using tools to scan for certain types of claims. Saint Francis found success with improving oncology medication workflows, finding tens of thousands of dollars' worth of eligible savings on certain oncology medicines.Investing in Better Data Quality, Not VolumeTo improve data collection, Houston said self-education — both about different analytical resources and what use cases would have the biggest impact — is critical to optimizing data. Those tools may cost money, but it is important to concisely communicate the value proposition for compliance or savings when investing in new tools to improve how hospitals gather and process data.Resources:Episode 140: What Illinois 340B Advocates Did To Succeed on 340B ProtectionsIllinois Governor Signs 340B Contract Pharmacy Protections as Drugmakers File Lawsuits

Monday August 31, 2026 Veloxis Pharmaceuticals to Pay $46 Million to Settle False Claims Charge

Are GLP-1'S Killing The Restaurant Industry? GLP-1 drugs are mixing up how some Americans eat, but they're not the only force reshaping restaurant menus. We look at the growing trend towards smaller portions, more protein and social media-driven menu items. Guests: Dana Baggett, executive director, Restaurant Client Strategy, R.R. Donnelley; Maeve Webster, president, Menu Matters. Linktr.ee | Apple Podcasts | YouTube | SpotifyFacebook: @ViewpointsOnlineX: @viewpointsradioInstagram: @viewpointsradioFull ArchiveContact UsAffiliates & National Syndication Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Cancer Care Has Changed. Have Our Assumptions? Cancer screening and treatment are changing fast. Dr. Avishek Kumar, a medical oncologist and hematologist, joins us to explain how to reduce your risk of developing cancer and what's new in the world of cancer detection and treatment.   Guest: Dr. Avishek Kumar, medical oncologist and hematologist, practicing doctor, Regional Cancer Care Associates   Are GLP-1'S Killing The Restaurant Industry? GLP-1 drugs are mixing up how some Americans eat, but they're not the only force reshaping restaurant menus. We look at the growing trend towards smaller portions, more protein and social media-driven menu items. Guests: Dana Baggett, executive director, Restaurant Client Strategy, R.R. Donnelley; Maeve Webster, president, Menu Matters. Linktr.ee | Apple Podcasts | YouTube | SpotifyFacebook: @ViewpointsOnlineX: @viewpointsradioInstagram: @viewpointsradioFull ArchiveContact UsAffiliates & National Syndication Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In 2000, Katie Couric underwent a live colonoscopy on national television following the death of her husband, Jay Monahan, from colorectal cancer at age 42. The broadcast demystified a procedure many Americans feared, led to an estimated 20% increase in colonoscopy screenings, and became one of the clearest examples of how public storytelling can change healthcare behavior.This episode examines how celebrities, journalists, filmmakers, and entertainers helped reshape the public conversation about cancer during a period when survivorship was becoming increasingly visible. As breakthroughs in targeted therapies, immunotherapy, and early detection allowed more people to live beyond cancer, public figures used their platforms to encourage screening, reduce stigma, and accelerate research. Their influence extended far beyond awareness campaigns, helping transform cancer from a private diagnosis into a national public health conversation.Central to this story is Laura Ziskin, the Hollywood producer behind Pretty Woman and the Spider-Man films, whose metastatic breast cancer diagnosis inspired the creation of Stand Up To Cancer. Working alongside Couric and leaders from entertainment, journalism, and biomedical research, Ziskin championed a new funding model that required multidisciplinary scientific collaboration, helping accelerate discoveries that contributed to multiple FDA-approved cancer therapies. The episode also highlights the advocacy of actor Patrick Dempsey, whose family's experience with ovarian cancer led to the creation of the Dempsey Center, expanding support for patients and caregivers beyond medical treatment.The story also asks what celebrity advocacy often leaves unsaid. Financial toxicity, caregiver burden, chronic pain, mental health, and the long-term effects of treatment rarely receive the same attention as dramatic diagnoses or breakthrough cures. As cancer survivorship continues to evolve, the greatest challenge may not be convincing people to care about cancer, but helping them understand what it truly means to live with and beyond it.RELATED LINKSStand Up To Cancer⁠Katie Couric Media⁠Dempsey Center⁠American Association for Cancer Research⁠National Cancer Institute⁠Dana-Farber Cancer Institute | Adult Survivorship Program⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"I'd already finished my cardiovascular unit. I'd finished my pulmonary unit. I had never heard about this in any of my classes." That was Dr. Joel Bervell's reaction to discovering that a device used every day in hospitals -- the pulse oximeter -- reads less accurately on darker skin tones. He posted a 30-second video about this consequential discrepancy that, to his utter surprise, gained over 500,000 views by the next morning. That video launched Dr. Bervell into orbit as a social media presence and created his identity as The Medical Mythbuster. In just a few years, he's built a following of two million people, earned a Peabody Award and was named to the inaugural Time 100 Creators list, all while finishing his residency.  On this episode of Raise the Line, host Lindsey Smith welcomes Dr. Bervell to explore the roots of this kind of bias and the real world impact of drawing attention to it. “The most impactful biases in medicine exist because no one stops to ask who was included in the original data and who was left out,” Dr. Bervell explains. Stay tuned to also learn about: His YouTube animated series The Doctor is In which helps kids understand how their bodies work, as well as providing medical role models; How to build trust with marginalized communities; His forthcoming book, The Default Body which examines who medicine was actually designed for. Mentioned in this episode:Dr. Bervell on InstagramTikTok ChannelFacebook"The Doctor Is In" Show If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and Nutrition Dr. Randi Shannon said she was going to blow our minds, and she delivered! In this episode of MaternalRx, pharmacist Danielle Plummer, PharmD, sits down with Dr. Shannon, a traditional naturopath who uses Face, Tongue and Nail Analysis, an approach she describes as rooted in thousands of years of traditional medicine. Their conversation explores pregnancy preparation, nutrition, nausea and vomiting, minerals, essential oils, disease prevention, and Dr. Shannon's belief that the face, tongue, and fingernails can reveal clues about what is happening inside the body. The interview is followed by a commentary where Danielle puts her pharmacist hat on for an evidence-based debrief, examining several of the episode's most surprising claims and asking an essential healthcare question: What happens when an idea sounds biologically plausible, yet the clinical evidence has not been tested? Topics include Type 1 diabetes, Down syndrome, salt intake, peppermint oil in pregnancy, cholesterol, dietary oils, pharmaceuticals, nutrient requirements, and the important distinction between traditional naturopaths and licensed naturopathic doctors. This isn't a conversation about dismissing complementary medicine. It's about listening with curiosity while still asking important questions: What do we know? What don't we know? Where might an approach put a patient or pregnancy at risk, and where might it support the body's ability to heal? Stay through the end to hear Danielle's Takeaway! Section 1: Welcome and disclaimer Meet Dr. Randi Shannon What is a naturopath? Preparing the body for pregnancy Nausea in pregnancy and gut health What can fingernails tell us? Nutrients and claims about preventing or reversing disease What can the tongue reveal? What can the face reveal? Section 2: Evidence-Based Debrief Do we need exactly 60 minerals, 16 vitamins, 12 amino acids and 3 essential fatty acids? Is Type 1 diabetes created during the first trimester? Can Type 1 diabetes develop later in life? Can maternal nutrition reverse Down syndrome in utero? Peanuts, mold, aflatoxins and liver risk Peppermint essential oil during pregnancy Are Americans “undersalted”? Pharmaceuticals, synthetic drugs and side effects Cholesterol, dietary oils and reproductive health Traditional vs. licensed naturopaths Danielle's takeaway About Dr. Randi Shannon Randi Shannon, ND, is a Florida-based traditional naturopath known for her use of Face, Tongue and Nail Analysis. She works with clients virtually in Florida, across the United States and internationally. Learn more: TheBodyCan.com RandiShannon.com/face-tongue-nail-analysis/ (844) 275-1056 About the Host Danielle Plummer, PharmD, is a pharmacist, antepartum doula, and founder of Obstet-Rx. Also known as HG Pharmacist, she helps women navigate Hyperemesis Gravidarum and medication use in complex pregnancies through education, advocacy and personalized medicine. HGPharmacist.com LinkedIn: linkedin.com/in/daniellerplummer HG Support Group: facebook.com/HGClinicalSolutions Important Listener Note This episode contains health and medical claims made by a guest that may differ from or contradict current evidence-based medical guidance. The guest's statements represent her perspectives and should not be interpreted as endorsement by MaternalRx, Danielle Plummer, or the Pharmacy Podcast Network. The second half of the episode provides Danielle's evidence-based commentary on several of these claims. This podcast is for educational purposes and is not a substitute for individualized medical care. Patients should discuss medications, supplements, herbal products, essential oils, and other treatments with an appropriately qualified healthcare professional.

Dr. Jack Kreindler joins the show to discuss longevity, human performance, physiological medicine, and what it truly takes to preserve vitality as we age. Together, we explore why longevity should go beyond disease prevention and quick fixes to focus on building the physical capacity, resilience, and independence needed to thrive throughout life.We dive into:Redefining longevity around vitality, healthspan, and physiological capacityWhat extreme environments and human performance science can teach us about agingUsing VO2 max, body composition, and functional assessments to understand health trajectoriesWhy treating everyday patients more like athletes can support long-term performanceBuilding strength, mobility, and resilience to maintain independence with ageWhy foundational physiology should come before peptides and other longevity interventionsGLP-1s, emerging therapies, and the importance of thoughtful risk managementThe limitations of quick fixes and longevity trends popularized on social mediaHow clinicians can incorporate performance science and physiological medicine into patient careWhy preserving physical and cognitive function is central to a meaningful approach to longevity

In 2006, a landmark report titled Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer confirmed what young survivors had been saying for years. While survival rates for children and older adults had steadily improved, adolescents and young adults had experienced decades of stalled progress. They had become cancer's lost generation.This episode explores how young adult survivors transformed their shared isolation into one of the most influential grassroots movements in cancer advocacy. Diagnosed during the years typically devoted to education, careers, relationships, and starting families, patients between the ages of 15 and 39 confronted challenges that extended far beyond treatment. Fertility preservation, sexual health, employment, financial toxicity, insurance, and long-term quality of life were rarely discussed in oncology clinics, leaving many to navigate survivorship alone.The episode follows advocates including Tamika Felder, Lindsay Avner, Heidi Adams, Doug Ulman, and Dr. Archie Bleyer, whose research and advocacy fundamentally changed how medicine understands adolescent and young adult cancer. Through organizations including Planet Cancer, Fertile Hope, the Lance Armstrong Foundation, and later Stupid Cancer, survivors built online communities, educational resources, conferences, and national partnerships that challenged long-standing assumptions about cancer care. Their work helped establish fertility preservation as a standard discussion before treatment, expanded research dedicated to adolescent and young adult oncology, and elevated quality of life as a critical clinical outcome alongside survival.The movement also demonstrated the power of lived experience to reshape medicine. Survivors became researchers, educators, nonprofit founders, and policy advocates, insisting that cancer care account not only for years of life saved, but for the lives patients hoped to build afterward.What began as a search for peers evolved into a national movement that permanently transformed adolescent and young adult oncology. Today, dedicated research programs, clinical fellowships, survivorship resources, and patient advocacy organizations continue to build on the foundation these young cancer mavericks created.RELATED LINKSNational Cancer Institute | Adolescent and Young Adult (AYA) Cancer Program⁠Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer⁠American Society of Clinical Oncology | Fertility Preservation Guidelines⁠Stupid Cancer⁠Livestrong Foundation⁠Journal of Adolescent and Young Adult Oncology⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A new research paper reframes weight loss for the GLP-1 era and it puts supervised resistance training at the center of the conversation. This 52-page paper, published in the journal Pharmaceuticals, is focused on optimizing weight loss in the GLP-1 era and is primarily written for physicians. Hosts Luke Carlson and Rachel Chonko break down what it means for club operators working with a growing population of GLP-1 users. This Episode Covers: - New research introduces "high-quality weight loss" — why the scale is no longer the metric that matters. - Muscle preservation becomes the industry's next big job as more members turn to GLP-1 medications. - Why GLP-1s, resistance training, and nutrition need to work together, not separately. - The case for supervised resistance training as clubs' biggest commercial opportunity in the GLP-1 era.

In 2006, the Institute of Medicine published From Cancer Patient to Cancer Survivor: Lost in Transition, concluding that millions of Americans were surviving cancer only to find themselves navigating a healthcare system unprepared for life after treatment. The report challenged oncology to recognize that curing cancer was not the end of care, but the beginning of survivorship.This episode explores how the growing cancer survivorship movement exposed the long-term consequences of cancer treatment that medicine had largely overlooked. As survival rates improved following the National Cancer Act of 1971, millions of survivors faced chronic fatigue, neuropathy, infertility, cognitive impairment, financial hardship, employment discrimination, anxiety, depression, and post-traumatic stress. These were not rare complications. They became defining features of survivorship for many patients.Drawing on the work of oncologist Dr. Patricia Ganz, survivor advocate Ellen Stovall, and researchers, clinicians, and survivors across the country, the episode examines how survivorship research expanded beyond recurrence and mortality to include quality of life, psychosocial care, rehabilitation, and long-term follow-up. Their efforts helped establish survivorship care plans, multidisciplinary survivorship clinics, and a broader understanding that cancer affects every aspect of a person's life long after treatment ends.The episode also confronts persistent inequities in survivorship care. Insurance coverage often ends when treatment stops, supportive services remain inconsistent, financial toxicity continues to drive medical hardship, and racial, geographic, and socioeconomic disparities still influence who receives comprehensive follow-up care. For many survivors, finishing treatment simply marks the beginning of another struggle.Modern oncology increasingly recognizes that surviving cancer is measured by more than years of life. It is also measured by quality of life, dignity, access to care, and the ability to rebuild a future after treatment. That evolution remains one of the most significant legacies of the cancer survivorship movement.RELATED LINKSNational Academy of Medicine | ⁠From Cancer Patient to Cancer Survivor: Lost in Transition⁠National Cancer Institute Office of Cancer Survivorship⁠American Society of Clinical Oncology | Survivorship Compendium⁠CancerCare⁠HopeWell Cancer Support⁠National Coalition for Cancer Survivorship⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Despite gains in recent years, Black, Hispanic, and Asian communities are still under-represented in the U.S. nursing workforce. We're going to explore that gap and how to close it on this episode of Raise the Line from Elsevier with Dr. Ernest Grant, Vice Dean for Diversity, Equity, Inclusion and Belonging at the Duke University School of Nursing. "You get a patient who is more compliant when they see someone who looks like them, who is from their culture and who can advocate on their behalf," he tells host Lindsey Smith.  Dr. Grant bases that and other insights on a rich professional background that includes 50 years in nursing, being a leading advocate for his profession and breaking down barriers himself as a male nurse of color and the first man elected president of the American Nurses Association.  In this thoughtful conversation, Dr. Grant reflects on what it took to earn credibility in leadership roles, how he's navigating the political climate on DEI initiatives, and the causes and solutions to the persistent shortage in nursing faculty, among other pressing issues. Tune in for a uniquely-informed look at what it will take to build a stronger, more representative nursing profession. Mentioned in this episode: Duke University School of Nursing American Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In 1967, breast surgeon Dr. Harold P. Freeman arrived at Harlem Hospital expecting to treat cancer. Instead, he confronted a healthcare system where poverty, racism, lack of insurance, and institutional barriers often determined who lived long enough to receive treatment. Patients frequently arrived with advanced disease, not because medicine lacked answers, but because access to care had failed them.This episode explores how cancer survivorship expanded beyond medical breakthroughs to include healthcare access, health equity, and organized advocacy. Building on the early work of the National Coalition for Cancer Survivorship (NCCS), it examines the recognition that surviving cancer depended not only on research, but also on whether patients could navigate a fragmented healthcare system.Freeman responded by creating one of the nation's first patient navigation programs at Harlem Hospital in 1990. Community-based navigators helped patients overcome practical barriers including insurance, transportation, appointments, communication, and fear. The model dramatically improved timely diagnosis and treatment, increased breast cancer survival in Harlem, and ultimately inspired the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005, establishing navigation as a cornerstone of modern oncology care.The episode also follows cancer survivor Ellen Stovall, whose leadership transformed survivorship into a national policy movement. Through the NCCS, she united advocates across cancer types, fought for insurance protections, expanded access to clinical trials, helped shape the creation of the Office of Cancer Survivorship at the National Cancer Institute, and organized the landmark 1998 National March for Cancer Survivorship in Washington, D.C. Her work reframed survivorship as a public policy issue rather than a personal experience.Together, Freeman and Stovall demonstrated that scientific progress alone could not eliminate disparities in cancer outcomes. Their work established two enduring principles that continue to shape oncology today: patients need someone to help them navigate care, and survivors must have a voice in the policies that govern it. Modern cancer survivorship depends on both.RELATED LINKSNational Coalition for Cancer Survivorship⁠Harold P. Freeman Patient Navigation Institute⁠National Cancer Institute Office of Cancer Survivorship⁠Patient Navigator Outreach and Chronic Disease Prevention Act of 2005⁠American Cancer Society⁠Tuskegee Study Timeline | Centers for Disease Control and Prevention⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to a very, very, very special bonus episode of Out of Patients, and one unlike anything published on this feed before. For nearly 20 years, Matthew Zachary has handed these microphones to patients, caregivers, doctors, advocates, troublemakers, and people with something worth saying. This time, he handed them to his daughter. Hannah Greenzweig grew up around this show, and now she has commandeered the studio with 3 of her wonderfully creative high school friends to talk about something they built entirely themselves. There is an enormous amount of Dad Pride baked into this episode, along with the strange and wonderful realization that sometimes your kid grows up, takes your chair, takes your microphone, and produces a better show without you.Hannah Greenzweig, Michael Aidinov, Gwendolyn Baldini, and Astronomy are student artists from the Roundabout Youth Ensemble at James Madison High School in Brooklyn. Working alongside teaching artists from Roundabout Theatre Company, they spent a school year creating an original play from the ground up, writing every scene, developing every character, and producing the performance themselves.Instead of discussing a Broadway production, they dissect one they invented.Their play, Subject Matter, began with a room full of improbable ideas. Murderous bounce houses, pirate family sagas, underwater adventures, courtroom dance battles, and birthday parties at math museums all competed before the group settled on an absurd rivalry between New York's fictional History Museum and Math Museum. From there, they built a fully staged comedy about institutional competition, sabotage, oversized personalities, and the unexpected discovery that history and mathematics need each other more than either side wants to admit.The conversation pulls back the curtain on a creative process most audiences never see. The students explain how scenes evolved through constant rewrites, how characters emerged from improvisation, how costumes came together with last minute ingenuity, and how rehearsals often collapsed into uncontrollable laughter. They recount cutting favorite ideas, solving production problems with limited resources, and trusting each other enough to keep rewriting until the story worked.The episode also captures something harder to script: teenagers speaking honestly about collaboration without adults translating their experience. They celebrate classmates who stepped into unexpected roles, teachers who quietly held the production together, and the strange joy of creating something that exists only because everyone showed up.It is a conversation about theater, friendship, education, creativity, and what happens when 4 young artists get the microphones and the adults get out of the way.RELATED LINKSRoundabout Theatre CompanyRoundabout Youth EnsembleJames Madison High SchoolFEEDBACKLike this bonus episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A man is struck by a car on the streets of Los Angeles. In the emergency department, a CT scan ordered to look for traumatic injuries reveals something nobody expected: a mass in his colon. Days later, sitting across from Dr. Belinda Waltman, he calls the accident “a blessing in disguise.” Then he changes the subject. He is less worried about cancer than about whether he can afford to miss another day of work. In this season finale of Standard Deviation, host Dr. Oliver Bogler explores what happens when biomedical science collides with the realities of the healthcare safety net. Dr. Waltman, a primary care physician in Los Angeles County, specializes in expedited cancer workups for uninsured and underinsured patients. Every diagnosis arrives carrying another set of questions about housing, transportation, food insecurity, wages, and survival that rarely appear in medical records or scientific literature. For years, Waltman carried those stories without knowing how to bring them into the academic record. As a full-time clinician without a research lab, grant funding, or publication pipeline, she faced barriers familiar to many working scientists and physicians whose most important observations happen outside traditional research settings. With support from the Life Science Editors Foundation's JEDI program, those experiences became The Margins Matter, a narrative medicine essay published in JAMA that argues the social realities surrounding cancer care are not background details. They are part of the disease itself. Bogler traces how editorial mentorship transformed lived clinical experience into published scholarship while asking a larger question about who gets to shape the scientific record. The conversation examines cancer care, Medicaid, health-related social needs, medical publishing, and the structural incentives that determine which stories become evidence and which disappear from view.The result is a conversation about documentation, visibility, and why the margins of medicine often determine who survives long enough to benefit from its advances.RELATED LINKSDr. Belinda Waltman⁠The Margins Matter | JAMA⁠The Margins Matter | PubMed⁠Life Science Editors Foundation⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What does it take to compete on the world's biggest stage and then pivot to one of the most demanding training paths in professional life? Today's guest, Samantha "Sammy" Kolowrat, has done both, and she has some fascinating insights into the commonalities of those two worlds on this episode of Raise the Line. “Something that really drew me to medicine is the team atmosphere that's there as you work towards a common goal, and there's this level of intensity that's very reminiscent of the experiences I had as a professional athlete.” Originally from Prague, Kolowrat represented Czechia at six IIHF Women's World Championships and the 2022 Beijing Olympics, and also captained the Division I women's hockey team at the University of Vermont while earning degrees in biology and pharmacology.  As she starts an anesthesiology residency at Vanderbilt University, she credits her athletic career with shaping how she handles pressure, feedback, and teamwork in medicine. "The more I improve, the more knowledge I acquire, the more skills I hone, the better care my patients get," she tells host Lindsey Smith, describing what drew her to a field that rewards the same relentless fine-tuning as elite sports. This engaging conversation also explores: How crippling performance anxiety as a Division I athlete ended up preparing Kolowrat for the operating room; Why she was drawn to anesthesiology's "well-oiled machine" atmosphere; The mentorship gap she's working to close for the next generation of athlete-physicians. Mentioned in this episode: Vanderbilt University Anesthesiology Residency Program If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Dr. Jack is a cardiologist and a leading voice in holistic and integrative heart health. He's passionate about helping people prevent and reverse cardiovascular disease naturally through nutrition, lifestyle medicine, and root-cause approaches Socials:  Instagram: @Natural_Heart_Doctor X: @DrJackWolfson YouTube: @NaturalHeartDoctor Website: www.NaturalHeartDoctor.com Timestamps: 00:00 Trailer 00:40 Introduction 04:45 Reevaluating traditional medicine views 07:15 Questioning traditional health advice 12:48 Cholesterol misconceptions and marketing strategies 16:43 LDL's role in blood vessels 20:40 Lifestyle factors beyond diet 24:00 Discussing stress and heart disease 25:55 Understanding broken heart syndrome 30:06 Lifestyle changes over medical stats 34:12 Concerns about nuclear stress tests 36:02 Testing for oxidative stress and toxins 39:25 Longevity study findings and tips 43:50 Impact of environment on longevity 47:31 Stents and heart attack prevention 50:48 Where to find Dr. Wolfson Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

In 1986, 23 survivors, physicians, nurses, attorneys, and community organizers gathered in Albuquerque, New Mexico, for a weekend that would permanently change the language and politics of cancer. Working late into the night, they debated not only strategy, but identity, ultimately declaring that from the moment of diagnosis, every person with cancer is a survivor.This episode traces the social and political forces that gave birth to the modern cancer survivorship movement. As advances in early detection and treatment allowed more people to live beyond cancer, survivors discovered that finishing treatment did not mean returning to normal life. Many faced employment discrimination, loss of insurance, social stigma, infertility, chronic health complications, and a healthcare system that viewed survival as the end of care rather than the beginning of a new chapter.Against the backdrop of the civil rights, disability rights, and community health movements of the 1960s and 1970s, physicians, activists, and survivors challenged medicine's paternalistic culture and demanded a greater voice in decisions affecting their lives. Central to this story are physician and survivor Dr. Fitzhugh Mullan, whose landmark 1985 essay, Seasons of Survival, redefined survivorship as a lifelong continuum, and community organizer Katherine Logan, whose determination united dozens of grassroots organizations into what became the National Coalition for Cancer Survivorship.The coalition's founding established principles that continue to shape oncology today. Survivors were no longer defined solely by disease or treatment outcomes. Their experiences became evidence. Their voices became essential to clinical research, healthcare policy, and patient advocacy. By redefining survivorship as an ongoing experience rather than a destination, the movement challenged medicine to recognize the lasting physical, emotional, financial, and social consequences of cancer.The ideas forged during that weekend in Albuquerque became the foundation of modern cancer survivorship. Nearly 40 years later, the coalition's defining principle, that survivorship begins at diagnosis, continues to influence cancer care, research, policy, and the way millions of people understand life after cancer.RELATED LINKSNational Coalition for Cancer Survivorship⁠National Cancer Institute Office of Cancer Survivorship⁠The New England Journal of Medicine⁠Americans with Disabilities Act (ADA.gov)⁠Library of Congress | Civil Rights History Project⁠White Coat, Clenched Fist by Fitzhugh Mullan⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mid-August to mid-September marks the time every year when hospitals need to recertify for 340B. Failure to recertify in time could cost a hospital its ability to participate in 340B. 340B Health Associate Director of Policy and Compliance Rebecca Swartz joins us to walk listeners through the process.Why recertification is “exceptionally important”Swartz says annual recertification is not just important, it's also one of the central tenets of 340B compliance. All hospital types except critical access hospitals need to make sure they're meeting the minimum disproportionate share percentage threshold. Hospitals also need to affirm that they are nonprofit facilities and that all their registered parent and child sites continue to have reimbursable outpatient costs and charges on their Medicare cost reports.The cost of losing eligibility is highFailure to recertify 340B eligibility in a timely manner can lock hospitals out of their access to 340B pricing for a year or more. That could deprive a hospital of crucial resources to provide the care and support its patients need.Tips for a smooth recertificationSwartz says a key to making the process go smoothly is to start early and make sure hospital officials have the necessary worksheets and other documentation before the recertification process begins. Authorized officials (AOs) and primary contacts (PCs) should be on the lookout for returned tasks from the Health Resources & Services Administration (HRSA) and other messages to ensure their recertification process is complete. Taking screenshots of each step of the process also can help identify and fix discrepancies that might arise.ResourcesHospital Recertification Begins Aug. 10, Prepare Now!340B Health Registration and Recertification Resource Page340B Health Webinars

In 1971, President Richard Nixon signed the National Cancer Act, transforming cancer research with an unprecedented federal investment and launching what became known as the War on Cancer. The legislation did not emerge from scientific discovery alone. It was the culmination of decades of relentless advocacy by researchers, philanthropists, journalists, and patients who believed cancer demanded the same national commitment that had put astronauts on the Moon.This episode traces the origins of the cancer survivorship movement by returning to a time when cancer was rarely discussed in public, many physicians withheld diagnoses from their patients, and surgery offered few lasting cures. It follows the pioneering work of pathologist Dr. Sidney Farber, whose early chemotherapy research challenged conventional thinking, and Mary Lasker, whose political strategy, fundraising, and public campaigns helped transform cancer from a private tragedy into a national public health priority. Together, they built the coalition that reshaped federal support for oncology research and forever changed the relationship between science, government, and the American public.The story then turns to journalist and breast cancer survivor Rose Kushner, whose refusal to accept the standard one-step radical mastectomy challenged nearly a century of surgical dogma. Working alongside surgeon Dr. Bernard Fisher, Kushner helped bring evidence-based medicine to breast cancer treatment through randomized clinical trials that demonstrated less invasive surgery could achieve equivalent outcomes. Their efforts changed clinical practice, strengthened informed consent, and helped establish the principle that patients should participate in decisions about their own care.The breakthroughs explored in this episode extended far beyond new treatments. They redefined the role of patients in medicine, accelerated clinical research, and laid the foundation for modern cancer survivorship. The movement that followed would not simply help more people live longer. It would change what surviving cancer meant.RELATED LINKSNational Cancer Institute⁠National Cancer Act of 1971⁠American Cancer Society⁠Dana-Farber Cancer Institute⁠National Library of Medicine⁠The New England Journal of Medicine⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

An 11-year-old boy in rural Zambia once told Dr. Genesis Mwamba that he was about to attend school wearing shoes for the first time in his life. That moment, Dr. Mwamba says, crystallized why he started the Lead Me Back Foundation to provide school supplies and other support to marginalized communities in his native country.   As you'll learn in this inspiring installment in our NextGen Journeys series, Dr. Mwamba started the foundation in 2021while still a medical student because he had experienced the power of education as an “equalizer” in his own life, taking him from humble roots to a career in medicine. He and his colleagues have grown the bootstrapped organization to a point where it now provides hundreds of thousands of people across the country with educational access, climate education and community health clinics. “I've always been drawn to opportunities and initiatives that bring help to humankind,” he tells Raise the Line host Dr. Parsa Mohri. This episode also explores: What building "with" a community rather than "for" it looks like in practice; The storytelling strategy that attracted donors and partners; How his mother's untimely death inspired his commitment to preventive medicine.   Mentioned in this episode: Lead Me Back Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast